CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CVAC CureVac B.V.

未开盘 12-22 16:00:00 EST

4.12

-0.04

-0.96%

盘后4.05

-0.07-1.70%

17:56 EST

最高4.16	最低4.00	成交量305.28万
今开4.08	昨收4.16	日振幅3.72%
总市值9.28亿	流通市值5.19亿	总股本2.25亿
成交额1,244万	换手率2.43%	流通股本1.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CVAC","market":"US","secType":"STK","nameCN":"CureVac B.V.","latestPrice":4.12,"timestamp":1766437200000,"preClose":4.16,"halted":0,"volume":3052822,"hourTrading":{"tag":"盘后","latestPrice":4.05,"preClose":4.12,"latestTime":"17:56 EST","volume":151085,"amount":621525.71,"timestamp":1766444171830},"delay":0,"floatShares":125869472,"shares":225172749,"eps":0.936486,"marketStatus":"未开盘","change":-0.04,"latestTime":"12-22 16:00:00 EST","open":4.08,"high":4.155,"low":4.0001,"amount":12439810.043631999,"amplitude":0.037236,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.936486,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1766480400000},"marketStatusCode":0,"adr":0,"listingDate":1597377600000,"exchange":"NASDAQ","adjPreClose":4.16,"preHourTrading":{"tag":"盘前","latestPrice":4.06,"preClose":4.16,"latestTime":"09:29 EST","volume":84669,"amount":341622.90454500006,"timestamp":1766413782175},"postHourTrading":{"tag":"盘后","latestPrice":4.05,"preClose":4.12,"latestTime":"17:56 EST","volume":151085,"amount":621525.71,"timestamp":1766444171830},"volumeRatio":1.722339,"impliedVol":1.2624,"impliedVolPercentile":0.628},"requestUrl":"/m/hq/s/CVAC","defaultTab":"news","newsList":[{"id":"1196264094","title":"BioNTech完成对CureVac的收购","url":"https://stock-news.laohu8.com/highlight/detail?id=1196264094","media":"投资观察","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196264094?lang=zh_cn&edition=full","pubTime":"2025-12-18 18:14","pubTimestamp":1766052856,"startTime":"0","endTime":"0","summary":"12月18日 - BioNTech SE宣布已完成对CureVac B.V.的收购，约86.75%的CureVac股份已被拍卖。CureVac将继续按照现有的业务流程运营，并将完成必要的分析，以确定未来的组织和投资组合结构。预计在2026年1月将强制收购剩余股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4139","BNTX","BK4548","BK4535","BK4585","BK4588","CVAC","BK4568"],"gpt_icon":0},{"id":"1174710771","title":"BioNTech建议CureVac股东在2025年12月2日星期二东部时间下午6点前递交其股票","url":"https://stock-news.laohu8.com/highlight/detail?id=1174710771","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174710771?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:48","pubTimestamp":1764161321,"startTime":"0","endTime":"0","summary":"11月26日 - BioNTech SE宣布，CureVac于2025年11月25日举行的特别股东大会上批准了与其公开收购（“要约”）有关的事项，涉及CureVac N.V.（NASDAQ：CVAC，简称“CureVac”）的所有已发行股票。CureVac的股东被建议在2025年12月2日星期二东部时间下午6点之前递交他们的股票。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CVAC","BK4585","BK4548","BK4139","BNTX","BK4588","BK4568","BK4551","BK4535"],"gpt_icon":0},{"id":"1110169712","title":"Curevac重申其预期现金流可持续至2028年","url":"https://stock-news.laohu8.com/highlight/detail?id=1110169712","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1110169712?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:24","pubTimestamp":1763987068,"startTime":"0","endTime":"0","summary":"2025年11月24日 - CureVac B.V.（CUREVAC NV）发布了第三季度的财报，第三季度收入为5410万欧元，超过IBES预估的334万欧元。同时，第三季度的息税前利润（EBIT）为3.102亿欧元。CureVac B.V.重申其预计的现金流将持续至2028年。此外，德国联邦反垄断局已批准BioNTech SE与CureVac的交易。在截至2025年9月30日的三个和九个月中，CureVac B.V.的净财务结果分别为260万欧元的亏损和220万欧元的利润。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BNTX","BK4568","BK4585","BK4139","BK4588","BK4535","CVAC","BK4548"],"gpt_icon":0},{"id":"1130262074","title":"CureVac B.V. - 截至2025年9月30日的三个月和九个月净财务结果分别为亏损260万欧元和盈利220万欧元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130262074","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130262074?lang=zh_cn&edition=full","pubTime":"2025-11-24 20:14","pubTimestamp":1763986452,"startTime":"0","endTime":"0","summary":"CureVac B.V. - 截至2025年9月30日的三个月和九个月净财务结果分别为亏损260万欧元和盈利220万欧元","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4551","BK4139","CVAC"],"gpt_icon":0},{"id":"1178732043","title":"德国联邦卡特尔办公室批准BioNTech SE收购CureVac B.V.","url":"https://stock-news.laohu8.com/highlight/detail?id=1178732043","media":"投资观察","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178732043?lang=zh_cn&edition=full","pubTime":"2025-10-14 16:51","pubTimestamp":1760431913,"startTime":"0","endTime":"0","summary":"德国联邦卡特尔办公室宣布，已批准BioNTech SE对CureVac B.V.的收购交易。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BNTX","CVAC","BK4535","BK4548","BK4568","BK4551","BK4139","BK4585","BK4588"],"gpt_icon":0},{"id":"2557417475","title":"CureVac与辉瑞/BioNTech专利纠纷达成和解  葛兰素史克(GSK.US)获高额赔偿","url":"https://stock-news.laohu8.com/highlight/detail?id=2557417475","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557417475?lang=zh_cn&edition=full","pubTime":"2025-08-08 16:51","pubTimestamp":1754643094,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["159837","BK4585","LU0203347892.USD","LU1023059063.AUD","BK4568","BK4550","BK4139","GSK","LU1066051498.USD","IE000M9KFDE8.USD","LU1202635105.USD","LU0122379950.USD","LU1015430645.USD","PFE","LU0306807586.USD","LU0225771236.USD","SG9999002224.SGD","LU1035777561.USD","SG9999001176.USD","LU0971552830.HKD","LU1400636657.SGD","SG9999013999.USD","CVAC","BK4551","BK5011","LU1400636491.USD","BK4534","LU1302929846.USD","BNTX","LU0321505868.SGD","GSK.UK","IE0002270589.USD","LU1228905037.USD","BK4535","LU0203345920.USD","LU1098665638.USD","IE00B19Z3581.USD","LU1645745479.HKD","LU1046248800.SGD","159646","BK4533","SGXZ57979304.SGD","LU0456855351.SGD","LU1829250122.USD","LU0109981661.USD","BK4548","SG9999001176.SGD","LU1400636574.HKD","SG9999002232.USD","LU1481599808.USD"],"gpt_icon":0},{"id":"2550366020","title":"Curevac N.V.7月9日成交额为541.88万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550366020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550366020?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:45","pubTimestamp":1752111915,"startTime":"0","endTime":"0","summary":"美东时间2025年7月9日，Curevac N.V.成交额为541.88万美元，成交额较昨日增加53.91%，当日成交量为99.42万股。Curevac N.V.于2025年7月9日涨1.48%，报5.5美元，该股过去5个交易日涨1.66%，年初至今涨61.29%，过去60日涨92.31%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710094523a4416618&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710094523a4416618&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","GSK.UK","CVAC","BK4532","BK4585","LU1829250122.USD","BK4548","GSK","BK4139","BK4588","BK4007"],"gpt_icon":0},{"id":"2549577567","title":"Curevac N.V.7月7日成交额为478.86万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549577567","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549577567?lang=zh_cn&edition=full","pubTime":"2025-07-08 09:43","pubTimestamp":1751938985,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，Curevac N.V.成交额为478.86万美元，成交额较昨日增加17.56%，当日成交量为88.36万股。Curevac N.V.于2025年7月7日跌0.73%，报5.41美元，该股过去5个交易日涨0.56%，年初至今涨58.65%，过去60日涨98.9%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708094313a43cda86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708094313a43cda86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","GSK.UK","CVAC","GSK","BK4588","BK4548","BK4139","LU1829250122.USD","BK4585","BK4551","BK4007"],"gpt_icon":0},{"id":"2548332000","title":"Curevac N.V.7月3日成交额为407.32万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548332000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548332000?lang=zh_cn&edition=full","pubTime":"2025-07-04 09:43","pubTimestamp":1751593435,"startTime":"0","endTime":"0","summary":"美东时间2025年7月3日，Curevac N.V.成交额为407.32万美元，成交额较昨日增加15.16%，当日成交量为75.10万股。Curevac N.V.于2025年7月3日涨0.93%，报5.45美元，该股过去5个交易日涨0.93%，年初至今涨59.82%，过去60日涨105.66%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704094357a4ce5ae1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250704094357a4ce5ae1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4532","BK4548","GSK.UK","BK4551","CVAC","LU1829250122.USD","GSK","BK4585","BK4588"],"gpt_icon":0},{"id":"2548858706","title":"Curevac N.V.7月1日成交额为608.02万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548858706","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548858706?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:42","pubTimestamp":1751420568,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Curevac N.V.成交额为608.02万美元，成交额较昨日增加13.27%，当日成交量为112.38万股。Curevac N.V.于2025年7月1日跌0.37%，报5.41美元，该股过去5个交易日涨0.93%，年初至今涨58.65%，过去60日涨90.49%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702094252a4c9fc80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702094252a4c9fc80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4532","BK4007","BK4588","BK4585","BK4551","CVAC","GSK.UK","LU1829250122.USD","GSK","BK4139"],"gpt_icon":0},{"id":"2546773327","title":"Curevac N.V.6月27日成交额为414.03万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546773327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546773327?lang=zh_cn&edition=full","pubTime":"2025-06-28 09:43","pubTimestamp":1751075001,"startTime":"0","endTime":"0","summary":"美东时间2025年6月27日，Curevac N.V.成交额为414.03万美元，成交额较昨日减少4.82%，当日成交量为77.07万股。Curevac N.V.于2025年6月27日跌0.37%，报5.38美元，该股过去5个交易日跌1.1%，年初至今涨57.77%，过去60日涨97.79%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628094330a4c238ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628094330a4c238ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BK4007","GSK","BK4585","BK4139","BK4588","CVAC","GSK.UK","BK4548","BK4532","LU1829250122.USD"],"gpt_icon":0},{"id":"2546473772","title":"瑞银：下调CureVac(CVAC.US)评级，由买入调整至中性评级, 目标价由12.00美元调整至5.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2546473772","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546473772?lang=zh_cn&edition=full","pubTime":"2025-06-26 23:31","pubTimestamp":1750951889,"startTime":"0","endTime":"0","summary":"瑞银：下调CureVac(CVAC.US)评级，由买入调整至中性评级, 目标价由12.00美元调整至5.50美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/06/26233151332050.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CVAC"],"gpt_icon":0},{"id":"2546527538","title":"Curevac N.V.6月25日成交额为600.17万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546527538","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546527538?lang=zh_cn&edition=full","pubTime":"2025-06-26 09:43","pubTimestamp":1750902230,"startTime":"0","endTime":"0","summary":"美东时间2025年6月25日，Curevac N.V.成交额为600.17万美元，成交额较昨日增加83.59%，当日成交量为111.58万股。Curevac N.V.于2025年6月25日涨1.49%，报5.44美元，该股过去5个交易日跌1.09%，年初至今涨59.53%，过去60日涨82.55%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094355a4be3f19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626094355a4be3f19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","GSK","GSK.UK","BK4532","LU1829250122.USD","BK4551","BK4139","BK4585","BK4588","BK4007","CVAC"],"gpt_icon":0},{"id":"2546268577","title":"Curevac N.V.6月24日成交额为326.91万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546268577","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546268577?lang=zh_cn&edition=full","pubTime":"2025-06-25 09:41","pubTimestamp":1750815705,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日，Curevac N.V.成交额为326.91万美元，成交额较昨日减少20.62%，当日成交量为60.89万股。Curevac N.V.于2025年6月24日跌0.65%，报5.36美元，该股过去5个交易日跌2.9%，年初至今涨57.18%，过去60日涨91.43%。CureVac 曾与葛兰素史克合作开发第二代季节性流感和 COVID-19 疫苗以及禽流感疫苗。该公司其他研发管线中的候选产品还包括针对肿瘤的 mRNA 疫苗和涵盖肿瘤、肝脏及眼部疾病的分子疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625094147a4bc61ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625094147a4bc61ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","GSK.UK","BK4532","GSK","LU1829250122.USD","BK4139","BK4007","BK4551","BK4588","BK4585","BK4548"],"gpt_icon":0},{"id":"2517567923","title":"Curevac N.V.盘中异动 下午盘急速拉升5.00%报3.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517567923","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517567923?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:00","pubTimestamp":1741201228,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时00分，Curevac N.V.股票出现异动，股价大幅拉升5.00%。截至发稿，该股报3.15美元/股，成交量35.3715万股，换手率0.16%，振幅4.00%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为1.79%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306030028989d7fd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306030028989d7fd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BK4548","BK4139","CVAC"],"gpt_icon":0},{"id":"2516378056","title":"Curevac N.V.盘中异动 股价大涨5.16%报3.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516378056","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516378056?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:32","pubTimestamp":1741012322,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时32分，Curevac N.V.股票出现波动，股价大幅上涨5.16%。截至发稿，该股报3.26美元/股，成交量2.1514万股，换手率0.01%，振幅1.51%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.21%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223203abe6334d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223203abe6334d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","BK4139","BK4548","CVAC"],"gpt_icon":0},{"id":"2512346480","title":"Curevac N.V.盘中异动 急速下跌5.11%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512346480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512346480?lang=zh_cn&edition=full","pubTime":"2025-02-20 01:39","pubTimestamp":1739986795,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日01时39分，Curevac N.V.股票出现波动，股价快速跳水5.11%。截至发稿，该股报3.34美元/股，成交量23.8431万股，换手率0.11%，振幅3.55%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.47%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220013955988b4fd1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220013955988b4fd1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4551","BK4139","BK4548"],"gpt_icon":0},{"id":"2512380198","title":"Curevac N.V.盘中异动 快速跳水5.11%报3.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512380198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512380198?lang=zh_cn&edition=full","pubTime":"2025-02-19 01:28","pubTimestamp":1739899714,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日01时28分，Curevac N.V.股票出现异动，股价大幅跳水5.11%。截至发稿，该股报3.46美元/股，成交量52.0251万股，换手率0.23%，振幅3.84%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.55%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190128349627b4a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190128349627b4a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4139","BK4551","BK4548"],"gpt_icon":0},{"id":"2510866370","title":"Curevac N.V.盘中异动 早盘快速上涨6.98%报3.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510866370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510866370?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197901,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Curevac N.V.股票出现异动，股价大幅上涨6.98%。截至发稿，该股报3.83美元/股，成交量4.5724万股，换手率0.02%，振幅0.00%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为0.38%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223141abc9a4e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223141abc9a4e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","BK4551","CVAC"],"gpt_icon":0},{"id":"2509251927","title":"Curevac N.V.盘中异动 临近收盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509251927","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509251927?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:58","pubTimestamp":1738789096,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时58分，Curevac N.V.股票出现波动，股价大幅拉升5.15%。截至发稿，该股报3.78美元/股，成交量39.0769万股，换手率0.17%，振幅4.60%。Curevac N.V.股票所在的生物技术行业中，整体涨幅为1.98%。Curevac N.V.公司简介：CureVac NV是一家总部位于德国的生物制药公司，利用信使核糖核酸开发疫苗和治疗方法。Curevac与GSK合作开发了第二代季节性流感和新冠疫苗，以及禽流感疫苗。该公司的其他候选物质包括涵盖肿瘤，肝脏和眼部疾病的肿瘤学和分子疗法的mRNA疫苗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206045816abc3cc74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206045816abc3cc74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CVAC","BK4548","BK4139","BK4551"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.curevac.com","stockEarnings":[{"period":"1week","weight":-0.176},{"period":"1month","weight":-0.1809},{"period":"3month","weight":-0.2313},{"period":"6month","weight":-0.2426},{"period":"1year","weight":0.4355},{"period":"ytd","weight":0.2082}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":0.0391},{"period":"3month","weight":0.0326},{"period":"6month","weight":0.128},{"period":"1year","weight":0.1585},{"period":"ytd","weight":0.1685}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Curevac N.V.于2020年4月7日根据荷兰法律注册成立。该公司是一家全球性的临床阶段生物制药公司，开发基于信使核糖核酸的新型转化药物，该药物具有改善人们生活的潜力。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.081893},{"month":2,"riseRate":0.2,"avgChangeRate":-0.099557},{"month":3,"riseRate":0.2,"avgChangeRate":-0.055603},{"month":4,"riseRate":0.6,"avgChangeRate":0.064149},{"month":5,"riseRate":0.8,"avgChangeRate":0.233107},{"month":6,"riseRate":0.4,"avgChangeRate":-0.089668},{"month":7,"riseRate":0.2,"avgChangeRate":-0.076476},{"month":8,"riseRate":0.2,"avgChangeRate":-0.023047},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.136579},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.099323},{"month":11,"riseRate":0.833333,"avgChangeRate":0.241614},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.161277}],"exchange":"NASDAQ","name":"CureVac B.V.","nameEN":"CureVac B.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CureVac B.V.(CVAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CureVac B.V.,CVAC,CureVac B.V.股票,CureVac B.V.股票老虎,CureVac B.V.股票老虎国际,CureVac B.V.行情,CureVac B.V.股票行情,CureVac B.V.股价,CureVac B.V.股市,CureVac B.V.股票价格,CureVac B.V.股票交易,CureVac B.V.股票购买,CureVac B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CureVac B.V.(CVAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CureVac B.V.(CVAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}